Encompass Health (EHC) forms joint venture with NCH Healthcare in Naples
Encompass Health Society EHC recently announced plans to form a joint venture (JV) with nonprofit multi-facility healthcare alliance NCH Healthcare System to open and operate an inpatient rehabilitation hospital in Naples, Florida.
The move is expected to improve inpatient rehabilitation services in Naples. The 50-bed freestanding hospital, currently under construction at 14305 Collier Boulevard, is expected to open in August 2022. Following launch, NCH Healthcare is expected to relocate its NCH Brookdale Center for Healthy Aging & Rehabilitation, an existing 54-bed rehabilitation facility . , at the new hospital.
The inpatient rehabilitation solution complements acute care services and helps patients restore their functional abilities. The board of directors of NCH Healthcare has given its approval to invest in this JV. The move is expected to improve the quality and reach of inpatient rehabilitation services in the community. Entering the joint venture is in line with Encompass Health’s strategy to focus on more profitable inpatient rehabilitation operations.
EHC is set to streamline its global business through a spin-off of its home health and palliative care businesses on July 1, 2022. Following the separation, Encompass Health will have a single reportable segment, which is patient rehabilitation. hospitalized. Its net operating income for 2022 is expected to be between $4,250 million and $4,300 million. This unit reported net operating revenue of $4,015 million in 2021. EHC plans to add 100-150 beds and 6-10 de novos per year during 2022-2026.
Following the split, the new entity will be called Enhabit and will have two segments to present, namely home healthcare and palliative care. Management expects Enhabit’s net services revenue to be between $1,080 million and $1,120 million for 2022.
Shares of Encompass Health are down 30.4% over the past year compared to the 51.1% drop in the industry to which it belongs.
Image source: Zacks Investment Research
Zacks Ranking and Key Picks
Encompass Health currently has a Zacks Rank #3 (Hold). Some top ranked actions in the medical field are Select Medical Holdings Corporation SEM, Omega Therapeutics, Inc. OMGA and Progyny, Inc. PGNY, each carrying a Zacks Rank #2 (Buy) at present. You can see the full list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks consensus estimate for Select Medical’s earnings is currently pegged at $2.19 per share. SEM has seen an upward revision in estimates over the past 60 days versus none in the opposite direction.
Earnings for Select Medical have exceeded estimates in each of the past four quarters, averaging 42%.
The Zacks consensus estimate for Omega Therapeutics earnings shows a 28.9% increase over the previous year’s figure. OMGA has seen three upward revisions to estimates and no downward movement in the past 60 days.
Omega Therapeutics’ earnings have exceeded estimates twice in the past four quarters and missed the target the other two times.
The Zacks consensus estimate for Progyny’s bottom line in 2022 has improved 4.5x over the past 60 days. PGNY has seen three upward estimate revisions in the same period versus none in the opposite direction.
Progyny’s earnings have exceeded estimates in each of the past four quarters, averaging 169.7%.
Special Report: The 5 Best IPOs for Your Portfolio
Today you have the chance to enter the ground floor of one of the best investment opportunities of the year. As the world continues to benefit from an ever-changing internet, a handful of innovative tech companies are poised to reap immense rewards – and you can put yourself in a position to reap the benefits. One is about to disrupt the online communication industry. Brilliantly designed to build online communities, this stock is about to explode when it goes public. With the strength of our economy and record amounts of money pouring into IPOs, you don’t want to miss this opportunity.
>> See Zacks’ Hottest IPOs Now
Click to get this free report
Select Medical Holdings Corporation (SEM): Free Stock Analysis Report
Encompass Health Corporation (EHC): Free Stock Analysis Report
Progyny, Inc. (PGNY): Free Stock Analysis Report
Omega Therapeutics, Inc. (OMGA): Free Stock Analysis Report
To read this article on Zacks.com, click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.